Related references
Note: Only part of the references are listed.EGFR Mutations in Indian Lung Cancer Patients: Clinical Correlation and Outcome to EGFR Targeted Therapy
Vanita Noronha et al.
PLOS ONE (2013)
Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS-Mutant Cancers
Snjezana Dogan et al.
CLINICAL CANCER RESEARCH (2012)
Frequency of Driver Mutations in Lung Adenocarcinoma from Female Never-Smokers Varies with Histologic Subtypes and Age at Diagnosis
Yang Zhang et al.
CLINICAL CANCER RESEARCH (2012)
Epidemiology of lung cancer in India: Focus on the differences between non-smokers and smokers: A single-centre experience
V Noronha et al.
INDIAN JOURNAL OF CANCER (2012)
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rafael Rosell et al.
LANCET ONCOLOGY (2012)
Frequency of EGFR and KRAS Mutations in Lung Adenocarcinomas in African Americans
J. Matthew Reinersman et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
Caicun Zhou et al.
LANCET ONCOLOGY (2011)
Screening for EGFR mutations in lung cancer, a report from India
Rashmita Sahoo et al.
LUNG CANCER (2011)
The different clinical significance of EGFR mutations in exon 19 and 21 in non-small cell lung cancer patients of China
M. Li et al.
NEOPLASMA (2011)
Comparable rate of EGFR kinase domain mutation in lung adenocarcinomas from Chinese male and female never-smokers
Yi-hua Sun et al.
ACTA PHARMACOLOGICA SINICA (2010)
Frequency of and variables associated with the EGFR mutation and its subtypes
Tomoaki Tanaka et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
EGFR T790M Mutation: A Double Role in Lung Cancer Cell Survival?
Kenichi Suda et al.
Journal of Thoracic Oncology (2010)
Reconstructing Indian population history
David Reich et al.
NATURE (2009)
A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms
Damla Olcaydu et al.
NATURE GENETICS (2009)
Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer.
Rafael Rosell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
Tony S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors
A. F. Gazdar
ONCOGENE (2009)
Structure and clinical relevance of the epidermal growth factor receptor in human cancer
Amit Kumar et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
A Sensitive Method for Detecting EGFR Mutations in Non-small Cell Lung Cancer Samples with Few Tumor Cells
Miguel A. Molina-Vila et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Epidermal growth factor receptor mutations and their correlation with gefitinib therapy in patients with non-small cell lung cancer: A meta-analysis based on updated individual patient data from six medical centers in mainland China
Yi-Long Wu et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assay
K Endo et al.
LUNG CANCER (2005)
Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer
Y Tomizawa et al.
CLINICAL CANCER RESEARCH (2005)
Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients
H Cortes-Funes et al.
ANNALS OF ONCOLOGY (2005)
Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck
JW Lee et al.
CLINICAL CANCER RESEARCH (2005)
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers
H Shigematsu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib
W Pao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan
SF Huang et al.
CLINICAL CANCER RESEARCH (2004)
Mutations of the epidermal growth factor receptor gene in lung cancer:: Biological and clinical implications
T Kosaka et al.
CANCER RESEARCH (2004)
Measurement of gene expression in archival paraffin-embedded tissues - Development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay
M Cronin et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
